Effect of BFR Rehab After Achilles Tendon Rupture
Launched by THE METHODIST HOSPITAL RESEARCH INSTITUTE · Feb 8, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help people recover after an Achilles tendon rupture, which is a common injury in the back of the leg. The study explores whether a technique called blood flow restriction therapy can help reduce muscle shrinkage in the calf, improve recovery experiences, and speed up the time it takes to return to sports or regular activities after surgery.
To join the trial, participants need to be adults aged 18 or older who have had their Achilles tendon injury confirmed by a medical test and are undergoing a specific type of surgery. Unfortunately, people with certain health conditions like obesity, diabetes, or serious heart or lung diseases won't be eligible. If you decide to participate, you can expect to follow a rehabilitation program at a Methodist location, where researchers will monitor your progress and help you recover effectively. This trial is currently recruiting participants, so it's a great opportunity for those looking for new ways to enhance their recovery after an injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Achilles Rupture confirmed by MRI or Thompson Test
- • Adult
- • Receiving Percutaneous Achilles Repair System (PARS) or open repair
- • Proposed PT with Methodist Location
- Exclusion Criteria:
- • Obesity (BMI\>35)
- • Diabetes
- • Cardiovascular, renal, liver or pulmonary disease
- • Active infections
- • Cancer (current or treated within the past 2 years) or coagulation disorder
- • Physically unable to participate in the intervention
- • Unable to complete a minimum of 85% of the assigned rehabilitation sessions
- • Less than 18 years of age
- • Pregnant
About The Methodist Hospital Research Institute
The Methodist Hospital Research Institute (MHRI) is a leading clinical research organization dedicated to advancing medical science through innovative research and collaboration. Affiliated with the Methodist Hospital system, MHRI focuses on a broad spectrum of clinical trials, aiming to translate cutting-edge discoveries into effective therapies that enhance patient care. With a commitment to ethical standards and patient safety, the institute fosters partnerships between researchers, clinicians, and industry stakeholders, driving progress in fields such as cancer, cardiology, neurology, and more. Through its robust infrastructure and multidisciplinary approach, MHRI strives to improve health outcomes and contribute to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported